Your browser doesn't support javascript.
loading
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Morand, Eric; Pike, Marilyn; Merrill, Joan T; van Vollenhoven, Ronald; Werth, Victoria P; Hobar, Coburn; Delev, Nikolay; Shah, Vaishali; Sharkey, Brian; Wegman, Thomas; Catlett, Ian; Banerjee, Subhashis; Singhal, Shalabh.
Afiliación
  • Morand E; Monash University and Department of Rheumatology, Monash Health, Victoria, Australia.
  • Pike M; MedPharm Consulting, Inc., Raleigh, North Carolina.
  • Merrill JT; Oklahoma Medical Research Foundation, Oklahoma City.
  • van Vollenhoven R; Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Werth VP; University of Pennsylvania and the Michael J. Crescenz VA Medical Center, Philadelphia.
  • Hobar C; Bristol Myers Squibb, Princeton, New Jersey.
  • Delev N; Bristol Myers Squibb, Princeton, New Jersey.
  • Shah V; Bristol Myers Squibb, Princeton, New Jersey.
  • Sharkey B; Bristol Myers Squibb, Princeton, New Jersey.
  • Wegman T; Bristol Myers Squibb, Princeton, New Jersey.
  • Catlett I; Bristol Myers Squibb, Princeton, New Jersey.
  • Banerjee S; Bristol Myers Squibb, Princeton, New Jersey.
  • Singhal S; Bristol Myers Squibb, Princeton, New Jersey.
Arthritis Rheumatol ; 75(2): 242-252, 2023 02.
Article en En | MEDLINE | ID: mdl-36369798

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 3_tuberculosis / 4_tuberculosis / 6_immune_disorders / 6_musculoskeletal_diseases_rheumatic_disorders / 6_sense_organ_diseases Asunto principal: Anticuerpos Monoclonales Humanizados / Lupus Eritematoso Sistémico Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Arthritis Rheumatol Año: 2023 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 3_ND / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_nao_transmissiveis / 3_tuberculosis / 4_tuberculosis / 6_immune_disorders / 6_musculoskeletal_diseases_rheumatic_disorders / 6_sense_organ_diseases Asunto principal: Anticuerpos Monoclonales Humanizados / Lupus Eritematoso Sistémico Tipo de estudio: Clinical_trials Límite: Adult / Humans Idioma: En Revista: Arthritis Rheumatol Año: 2023 Tipo del documento: Article País de afiliación: Australia
...